Director Robert Hershberg fails to win majority support at AGM; Leslie Trigg resigns

Adaptive Biotechnologies Corp

Robert Hershberg received 44.02% for, 55.97% withhold/abstain in Class 1 director election; Katey Owen elected with 76.66%.
Leslie Trigg voluntarily resigned from board effective June 9, 2023; no disagreement with company.
Advisory vote on 2022 NEO compensation passed with 82.68% support.
Ernst & Young ratified as independent auditor for FY2023 with 99.72% shareholder approval.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Leslie Trigg

Director

ADPT · Adaptive Biotechnologies Corp

Effective: 2023-06-09
Filed: June 13, 2023, 7:59 PM ET

On June 9, 2023, Adaptive Biotechnologies Corporation (the " Company ") Board of Directors (the " Board ") member Leslie Trigg submitted her resignation from the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leslie Trigg resigned as Director at Adaptive Biotechnologies Corp.

Action: resigned
Role: Director

Exact text from the filing

On June 9, 2023, Adaptive Biotechnologies Corporation (the " Company ") Board of Directors (the " Board ") member Leslie Trigg submitted her resignation from the Board.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adaptive Biotechnologies Corp shareholders approved Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-09 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-09

Exact text from the filing

Proposal 3: Ramification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2023 Votes Submitted As % of Proposal Votes Broker Non Vote For 121,162,529 99.72 % 0 Against 200,965 0.16 % Withhold/Abstain 138,671 0.11 %

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adaptive Biotechnologies Corp shareholders approved Election of two Class 1 directors to the Board (Drs. Katey Owen and Robert Hershberg) at the 2023-06-09 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-09

Exact text from the filing

Proposal 1: Election of Class 1 Directors Dr. Katey Owen Votes Submitted As % of Proposal Votes Broker Non Vote For 83,072,262 76.66 % 13,147,625 Against - - Withhold/Abstain 25,282,278 23.33 % Dr. Robert Hershberg Votes Submitted As % of Proposal Votes Broker Non Vote For 47,703,083 44.02 % 13,147,625 Against - - Withhold/Abstain 60,651,457 55.97 %

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adaptive Biotechnologies Corp shareholders approved Advisory vote concerning the 2022 compensation of the Company's named executive officers at the 2023-06-09 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-09

Exact text from the filing

Proposal 2: Advisory Vote Concerning the 2022 Compensation of the Company's Named Executive Officers Votes Submitted As % of Proposal Votes Broker Non Vote For 89,592,587 82.68 % 13,147,625 Against 17,467,529 16.12 % Withhold/Abstain 1,294,424 1.19 %

View on SEC.gov

Browse all shareholder votes →

Adaptive Biotechnologies Corp filing history →

Source: SEC EDGAR

accession 0000950170-23-027702

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.